Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |